Your browser doesn't support javascript.
loading
MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response.
Zhang, Bin; Wang, Chun-Mei; Wu, Hao-Xiang; Wang, Feng; Chai, Yang-Yang; Hu, Ye; Wang, Bing-Jing; Yu, Zhou; Xia, Rong-Hua; Xu, Rui-Hua; Cao, Xue-Tao.
Affiliation
  • Zhang B; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, P. R. China.
  • Wang CM; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, P. R. China.
  • Wu HX; Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • Wang F; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Chai YY; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Hu Y; Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • Wang BJ; Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, P. R. China.
  • Yu Z; Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
  • Xia RH; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, P. R. China.
  • Xu RH; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, P. R. China.
  • Cao XT; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
Cancer Commun (Lond) ; 43(10): 1097-1116, 2023 10.
Article in En | MEDLINE | ID: mdl-37539769
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Stomach Neoplasms / Symporters Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Commun (Lond) Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Stomach Neoplasms / Symporters Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Commun (Lond) Year: 2023 Document type: Article